[Combination drug therapy in leprosy].
Copyright policy [Combination drug therapy in leprosy].
The importance of polichemotherapy in multibacilar leprosy (LL and LD) in patients without any previous therapy as in those diagnosticated and under monotherapy most of all in the resistance patients is presented. Sulphones, clofazimine and rifampicine are selected as first rate drugs and protionamide-etionamide as second rate drugs. The therapy plans with the association of two and three drugs and the convenience of continuing indefinitely with at least one of the drugs are presented insisting on the advantages of the clofazimine-sulphones and rifampicine-sulphones associations. The necessity of immunotherapy for recover of celular immunity against the bacilus, is the only form of preventing relapses and drug resistance.
Leprosy, Prothionamide, Humans, Drug Therapy, Combination, Leprostatic Agents, Drug Tolerance, Ethionamide, Rifampin, Clofazimine, Dapsone, Drug Administration Schedule
Leprosy, Prothionamide, Humans, Drug Therapy, Combination, Leprostatic Agents, Drug Tolerance, Ethionamide, Rifampin, Clofazimine, Dapsone, Drug Administration Schedule
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!